Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Signe Benzon Larsen"'
Autor:
Anne Katrine Graudal Levinsen, Trille Kristina Kjaer, Thomas Maltesen, Erik Jakobsen, Ismail Gögenur, Michael Borre, Peer Christiansen, Robert Zachariae, Søren Laurberg, Peter Christensen, Niels Kroman, Signe Benzon Larsen, Thea Helene Degett, Lisbet Rosenkrantz Hölmich, Peter de Nully Brown, Christoffer Johansen, Susanne K. Kjær, Lau Caspar Thygesen, Susanne Oksbjerg Dalton
Publikováno v:
BMC Health Services Research, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background Many cancer survivors experience late effects after cancer. Comorbidity, health literacy, late effects, and help-seeking behavior may affect healthcare use and may differ among socioeconomic groups. We examined healthcare use amon
Externí odkaz:
https://doaj.org/article/7e82405e058240728d2b43233326c0d5
Autor:
Anja Krøyer, Anne Sofie Friberg, Klaus Brasso, Martin Andreas Røder, Christoffer Johansen, Signe Benzon Larsen, John Thomas Helgstrand, Elisabeth Wreford Andersen, Susanne Oksbjerg Dalton
Publikováno v:
European Urology Oncology. 4:601-608
Background Development of depression in prostate cancer patients depends on multiple disease- and patient-related factors. Objective To investigate the risk of depression following radical prostatectomy focussing on the impact of surgery and subseque
Autor:
Signe Benzon Larsen, Christian Dehlendorff, Charlotte Skriver, Anton Pottegård, Søren Friis, Martin Andreas Røder, Klaus Brasso, Anne Katrine Duun-Henriksen
Publikováno v:
Larsen, S B, Dehlendorff, C, Skriver, C, Pottegård, A, Friis, S, Røder, M A, Brasso, K & Duun-Henriksen, A K 2022, ' Prescription rates for commonly used drugs before and after a prostate cancer diagnosis ', Cancer Causes and Control, vol. 33, no. 3, pp. 417-428 . https://doi.org/10.1007/s10552-021-01537-8
Purpose: To investigate differences in prescription rates of commonly used drugs among prostate cancer patients and cancer-free comparisons and between patients diagnosed with localized and non-localized disease. Methods: We conducted a register-base
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::576575574056a079f36c53281eb84fa7
https://portal.findresearcher.sdu.dk/da/publications/88a1a039-57ab-424c-acd3-31668eceb039
https://portal.findresearcher.sdu.dk/da/publications/88a1a039-57ab-424c-acd3-31668eceb039
Autor:
Anja Mehnert, Susanne K. Kjaer, Tim J. Hartung, Lars Vedel Kessing, Christoffer Johansen, Signe Benzon Larsen, Klaus Brasso, Ida Rask Moustsen, Anne Tjønneland, Anne Sofie Friberg, Susanne Oksbjerg Dalton, Nis P. Suppli, Elisabeth Wreford Andersen
Publikováno v:
Journal of Cancer Survivorship
Hartung, T J, Moustsen, I R, Larsen, S B, Wreford Andersen, E A, Suppli, N P, Johansen, C, Tjønneland, A, Friberg, A S, Kjær, S K, Brasso, K, Kessing, L V, Mehnert, A & Dalton, S O 2021, ' Antidepressant prescriptions and associated factors in men with prostate cancer and their female partners ', Journal of Cancer Survivorship, vol. 15, pp. 536–545 . https://doi.org/10.1007/s11764-020-00947-y
Hartung, T J, Moustsen, I R, Larsen, S B, Wreford Andersen, E A, Suppli, N P, Johansen, C, Tjønneland, A, Friberg, A S, Kjær, S K, Brasso, K, Kessing, L V, Mehnert, A & Dalton, S O 2021, ' Antidepressant prescriptions and associated factors in men with prostate cancer and their female partners ', Journal of Cancer Survivorship, vol. 15, pp. 536–545 . https://doi.org/10.1007/s11764-020-00947-y
Purpose To estimate the risk of first-time antidepressant prescriptions as a proxy for depression or anxiety and associated risk factors in patients with prostate cancer and their female partners. Methods We followed all men (n = 25,126) and their fe
Autor:
Christoffer Johansen, Signe Benzon Larsen, John Thomas Helgstrand, Martin Andreas Røder, Klaus Brasso, Nina Klemann, Lars Vedel Kessing, Anja Krøyer, Susanne Oksbjerg Dalton, Anne Sofie Friberg, Elisabeth Wreford Andersen
Publikováno v:
Psycho-oncologyREFERENCES. 30(11)
Objective To compare the risk of depression after diagnostic workup for prostate cancer (PCa), regardless of the histopathologic outcome, with that of a cancer-free population. Methods A nationwide cohort of Danish men who had a prostatic biopsy samp
Autor:
Sandra Miriam Kawa, Martin Andreas Røder, John Thomas Helgstrand, Klaus Brasso, Hein Vincent Stroomberg, Signe Benzon Larsen, Birgitte Grønkær Toft
Publikováno v:
Kawa, S M, Stroomberg, H V, Larsen, S B, Helgstrand, J T, Toft, B G, Brasso, K & Røder, M A 2021, ' Detection of Clinically Significant Prostate Cancer by Systematic TRUS-Biopsies in a Population-Based Setting Over a 20 Year Period ', Urology, vol. 155, pp. 20-25 . https://doi.org/10.1016/j.urology.2021.06.007
Objective: To assess the performance of systematic TRUS-biopsies in a population-based setting to detect clinically significant PCa (csPCa) in combination with age, clinical tumor category (cT), and prostate-specific antigen (PSA) in men referred for
Autor:
Ida Rask Moustsen, Anne Katrine Duun-Henriksen, Klaus Brasso, Anne Sofie Friberg, Susanne K. Kjaer, Susanne Oksbjerg Dalton, Anne Tjønneland, Christoffer Johansen, Signe Benzon Larsen
Publikováno v:
Acta Oncologica. 58:715-721
Background: High socioeconomic position is associated with better prognosis in prostate cancer patients but it is unknown if part of this association may be explained by socioeconomic differences i...
Autor:
Anne Tjønneland, Christian Dehlendorff, Jesper Hallas, Søren Friis, Klaus Brasso, Signe Benzon Larsen, Henrik Toft Sørensen, Anton Pottegård, Michael Borre, Charlotte Skriver
Publikováno v:
Skriver, C, Dehlendorff, C, Borre, M, Brasso, K, Larsen, S B, Tjønneland, A, Pottegård, A, Hallas, J, Sørensen, H T & Friis, S 2020, ' Associations of low-dose aspirin or other NSAID use with prostate cancer risk in the Danish Diet, Cancer and Health Study ', Cancer causes & control : CCC, vol. 31, no. 2, pp. 139-151 . https://doi.org/10.1007/s10552-019-01252-5
Skriver, C, Dehlendorff, C, Borre, M, Brasso, K, Larsen, S B, Tjønneland, A, Pottegård, A, Hallas, J, Sørensen, H T & Friis, S 2020, ' Associations of low-dose aspirin or other NSAID use with prostate cancer risk in the Danish Diet, Cancer and Health Study ', Cancer Causes and Control, vol. 31, no. 2, pp. 139-151 . https://doi.org/10.1007/s10552-019-01252-5
Skriver, C, Dehlendorff, C, Borre, M, Brasso, K, Larsen, S B, Tjønneland, A, Pottegård, A, Hallas, J, Sørensen, H T & Friis, S 2020, ' Associations of low-dose aspirin or other NSAID use with prostate cancer risk in the Danish Diet, Cancer and Health Study ', Cancer Causes and Control, vol. 31, no. 2, pp. 139-151 . https://doi.org/10.1007/s10552-019-01252-5
PURPOSE: Epidemiologic studies suggest that use of aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) may reduce prostate cancer risk. We examined these associations overall and according to clinical and lifestyle parameters.METHODS: We i
Autor:
Mette Nørgaard, Anton Pottegård, Michael Borre, Henrik Toft Sørensen, Charlotte Skriver, Klaus Brasso, Susanne Oksbjerg Dalton, Signe Benzon Larsen, Søren Friis, Jesper Hallas, Christian Dehlendorff
Publikováno v:
Skriver, C, Dehlendorff, C, Borre, M, Brasso, K, Larsen, S B, Dalton, S O, Nørgaard, M, Pottegård, A, Hallas, J, Sørensen, H T & Friis, S 2019, ' Use of low-dose aspirin and mortality after prostate cancer diagnosis : A nationwide cohort study ', Annals of Internal Medicine, vol. 170, no. 7, pp. 443-452 . https://doi.org/10.7326/M17-3085
Skriver, C, Dehlendorff, C, Borre, M, Brasso, K, Larsen, S B, Dalton, S O, Nørgaard, M, Pottegård, A, Hallas, J, Sørensen, H T & Friis, S 2019, ' Use of Low-Dose Aspirin and Mortality After Prostate Cancer Diagnosis : A Nationwide Cohort Study ', Annals of Internal Medicine, vol. 170, no. 7, pp. 443-452 . https://doi.org/10.7326/M17-3085
Skriver, C, Dehlendorff, C, Borre, M, Brasso, K, Larsen, S B, Dalton, S O, Nørgaard, M, Pottegård, A, Hallas, J, Sørensen, H T & Friis, S 2019, ' Use of Low-Dose Aspirin and Mortality After Prostate Cancer Diagnosis : A Nationwide Cohort Study ', Annals of Internal Medicine, vol. 170, no. 7, pp. 443-452 . https://doi.org/10.7326/M17-3085
Background: Recent studies suggest that aspirin use may improve survival in patients with prostate cancer.Objective: To assess the association between postdiagnosis use of low-dose aspirin and prostate cancer mortality.Design: Nationwide cohort study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3dca694fbf27323066bf6aebec6d1d71
https://portal.findresearcher.sdu.dk/da/publications/48d7fefa-ee56-41a5-8cf6-e6b163a184f0
https://portal.findresearcher.sdu.dk/da/publications/48d7fefa-ee56-41a5-8cf6-e6b163a184f0
Autor:
Tim J. Hartung, Anne Tjønneland, Elisabeth Wreford Andersen, Klaus Brasso, Susanne K. Kjaer, Ida Rask Moustsen, Anne Sofie Friberg, Christoffer Johansen, Signe Benzon Larsen, Maja Halgren Olsen, Susanne Oksbjerg Dalton
Publikováno v:
Acta oncologica (Stockholm, Sweden). 58(5)
Background: The risk of depression is inversely associated with socioeconomic position in the general population; however, studies on the association in cancer populations are limited. The aim was ...